AI Uncovered with Daniel O’Mahony (BioPharma 4.0 & The Role of AI in Drug Manufacturing)

BioPharma 4.0 & The Role of AI in Drug Manufacturing

In episode five, we are joined by Daniel O’Mahony. Dan is a senior manager of sales and business consulting with Körber Pharma, a pharma manufacturing software company.

In this episode, Tim and Daniel dive deep into the impact of AI on the pharmaceutical manufacturing processes and the delicate balance between digital transformation, risk, and productivity gains in life sciences. They discuss why Ireland has risen as a manufacturing and pharmaceutical hub. They evaluate the digital transformation of drug manufacturing, the role of AI on the process, and the future of personalized drugs.  

Along with his work at Körber, Dan lectures with the National Institute of Bioprocessing Research and Training and at the Atlantic Technical University covering topics like BioPharma 4.0 and digital transformation. Dan has a masters degrees in bioprocessing from ATU and in Pharmaceutical business and technology from Griffith College. He is based in Dublin, Ireland. 

“So on the one hand, you’re using AI models to write the submission documents, and then on the other hand, the regulators are actually using AI to read them.”

Listen and subscribe to AI Uncovered on all major podcast platforms:

• Apple Podcasts
• Spotify
• Amazon Music